Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Biphasic Insulin Aspart 30 in adults with type 1 or type 2 diabetes; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED